- MedTech company Outset Medical ( NASDAQ: OM ) announced on Monday that it won a national contract from the Department of Veterans Affairs to supply its Tablo Hemodialysis System for 106 VA hospitals in the U.S.
- The company received the contract from the department’s Strategic Acquisition Center (SAC) Office of Procurement.
- Some VA facilities already operate the Tablo system, an FDA-cleared hemodialysis solution for hospitals and homes.
- The contract “will further our mission to bring a technology-enabled, patient-centered approach to dialysis both in the acute and home setting,” OM’s Chief Executive Leslie Trigg remarked.
- The deal covers the use of Tablo for Slow Low-Efficiency Dialysis (SLED), home hemodialysis (HHD), and intermittent hemodialysis (IHD).
- The VA contract for Tablo comes days after the OM announced the FDA clearance of the system following an initial holdup of its shipments, pending a regulatory review of certain changes the company made since its initial approval.
For further details see:
Outset Medical awarded VA contract for hemodialysis